AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

A new study from Oregon Health & Science University has uncovered how small molecules within bacteria interact with proteins, ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

Equities research analysts at Needham & Company LLC assumed coverage on shares of Absci (NASDAQ:ABSI – Get Free Report) in a ...

A global team has made a significant advance in understanding how bacterial plasmids contribute to antibiotic resistance.

According to a 2023 PwC report, the AI market in healthcare was valued at $11 billion and is expected to grow to $188 billion by 2030. On January 21st, Oracle Co-founder Larry Ellison said during a ...

VALID, a Techbio startup dedicated to reshaping drug discovery with complex human induced pluripotent stem cell (iPSC) co-culture models that deliver increased predictive validity, has partnered with ...

Needham analyst has initiated coverage on Absci Corporation (NASDAQ:ABSI), a drug and target discovery company that harnesses ...

Charting, Price Performance, News & Related Contracts.

Absci Corp. (NASDAQ:ABSI) shares, currently trading at $3.22, received a positive outlook from Needham as the firm began coverage with a Buy rating and set a price target of $9.00. The stock has shown ...

We recently published a list of Complete List of All AI Companies Under $2 Billion Market Cap. In this article, we are going ...

H.C. Wainwright maintained a positive stance on Absci Corp (NASDAQ:ABSI), with an analyst from the firm reiterating a Buy rating and a price target of $7.00.